Basic Information
| LncRNA/CircRNA Name | LINC00152 |
| Synonyms | CYTOR, C2orf59, LINC00152, NCRNA00152 |
| Region | GRCh38_2:87454781-87636740 |
| Ensemble | ENSG00000222041 |
| Refseq | NR_024204 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR etc. |
| Sample | blood (plasma) |
| Expression Pattern | up-regulated |
| Function Description | Our results indicated that the relative expression levels of HULC and Linc00152 were up-regulated in HCC patients compared with controls. The HULC expression significantly correlated with tumor size and tumor capsular, while the expression of Linc00152 was significantly related to differentiation grade, tumor size, TNM stage and tumor capsular. |
| Pubmed ID | 26356260 |
| Year | 2015 |
| Title | HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma. |
External Links
| Links for LINC00152 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |